665 related articles for article (PubMed ID: 28731823)
1. Maternal-Fetal Outcomes in 34 Pregnant Women with Type 1 Diabetes in Sensor-Augmented Insulin Pump Therapy.
Gómez AM; Marín Carrillo LF; Arévalo Correa CM; Muñoz Velandia OM; Rondón Sepúlveda MA; Silva Herrera JL; Henao Carrillo DC
Diabetes Technol Ther; 2017 Jul; 19(7):417-422. PubMed ID: 28731823
[TBL] [Abstract][Full Text] [Related]
2. Impact of sensor-augmented pump therapy with predictive low-glucose management on hypoglycemia and glycemic control in patients with type 1 diabetes mellitus: 1-year follow-up.
Gómez AM; Henao DC; Taboada LB; Leguizamón G; Rondón MA; Muñoz OM; García-Jaramillo MA; León Vargas FM
Diabetes Metab Syndr; 2019; 13(4):2625-2631. PubMed ID: 31405686
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Efficacy and Safety of Sensor Augmented Insulin Pump Therapy with Low-Glucose Suspend Feature in Patients with Type 1 Diabetes.
Gómez AM; Marín Carrillo LF; Muñoz Velandia OM; Rondón Sepúlveda MA; Arévalo Correa CM; Mora Garzón E; Cuervo Diaz MC; Henao Carrillo DC
Diabetes Technol Ther; 2017 Feb; 19(2):109-114. PubMed ID: 28001445
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of sensor-augmented pump therapy (SAPT) with predictive low-glucose management in patients diagnosed with type 1 diabetes mellitus previously treated with SAPT and low glucose suspend.
Gómez AM; Henao DC; Imitola A; Muñoz OM; Sepúlveda MAR; Kattah L; Guerrero JS; Morros E; Llano JP; Jaramillo MG; León-Vargas F
Endocrinol Diabetes Nutr (Engl Ed); 2018 Oct; 65(8):451-457. PubMed ID: 29914817
[TBL] [Abstract][Full Text] [Related]
5. Diabetes Technology Use Among Pregnant and Nonpregnant Women with T1D in the T1D Exchange.
Polsky S; Wu M; Bode BW; DuBose SN; Goland RS; Maahs DM; Foster NC; Peters AL; Levy CJ; Shah VN; Beck RW
Diabetes Technol Ther; 2018 Aug; 20(8):517-523. PubMed ID: 29990438
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of sensor augmented insulin pump therapy with low-glucose suspend feature in older adults: A retrospective study in Bogota, Colombia.
Morros-González E; Gómez AM; Henao Carrillo DC; Ursida V; Serrano S; Rondón Sepúlveda MA; Muñoz Velandia OM
Diabetes Metab Syndr; 2021; 15(3):649-653. PubMed ID: 33813236
[TBL] [Abstract][Full Text] [Related]
7. Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study.
Petrovski G; Dimitrovski C; Bogoev M; Milenkovic T; Ahmeti I; Bitovska I
Diabetes Technol Ther; 2011 Nov; 13(11):1109-13. PubMed ID: 21751889
[TBL] [Abstract][Full Text] [Related]
8. Maternal and perinatal outcomes in pregnant women with type 1 diabetes treated with continuous subcutaneous insulin infusion and real time continuous glucose monitoring in two specialized centers in Medellin, Colombia.
Restrepo-Moreno M; Ramírez-Rincón A; Hincapié-García J; Palacio A; Monsalve-Arango C; Aristizabal-Henao N; Restrepo-Zapata C; Botero-Arango JF
J Matern Fetal Neonatal Med; 2018 Mar; 31(6):696-700. PubMed ID: 28264604
[TBL] [Abstract][Full Text] [Related]
9. Continuous Subcutaneous Insulin Infusion During Pregnancy in Women with Complicated Type 1 Diabetes Is Associated with Better Glycemic Control but Not with Improvement in Pregnancy Outcomes.
Kekäläinen P; Juuti M; Walle T; Laatikainen T
Diabetes Technol Ther; 2016 Mar; 18(3):144-50. PubMed ID: 26502287
[TBL] [Abstract][Full Text] [Related]
10. Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.
Imbergamo MP; Amato MC; Sciortino G; Gambina M; Accidenti M; Criscimanna A; Giordano C; Galluzzo A
Clin Ther; 2008 Aug; 30(8):1476-84. PubMed ID: 18803989
[TBL] [Abstract][Full Text] [Related]
11. Glycemic control and perinatal outcomes of pregnancies complicated by type 1 diabetes: influence of continuous subcutaneous insulin infusion and lispro insulin.
Chico A; Saigi I; García-Patterson A; Santos MD; Adelantado JM; Ginovart G; de Leiva A; Corcoy R
Diabetes Technol Ther; 2010 Dec; 12(12):937-45. PubMed ID: 21128840
[TBL] [Abstract][Full Text] [Related]
12. Insulin lispro therapy in pregnancies complicated by type 1 diabetes: glycemic control and maternal and fetal outcomes.
Garg SK; Frias JP; Anil S; Gottlieb PA; MacKenzie T; Jackson WE
Endocr Pract; 2003; 9(3):187-93. PubMed ID: 12917059
[TBL] [Abstract][Full Text] [Related]
13. Fetal growth in women managed with insulin pump therapy compared to conventional insulin.
Kernaghan D; Farrell T; Hammond P; Owen P
Eur J Obstet Gynecol Reprod Biol; 2008 Mar; 137(1):47-9. PubMed ID: 18006209
[TBL] [Abstract][Full Text] [Related]
14. Benefits, risks, costs, and patient satisfaction associated with insulin pump therapy for the pregnancy complicated by type 1 diabetes mellitus.
Gabbe SG; Holing E; Temple P; Brown ZA
Am J Obstet Gynecol; 2000 Jun; 182(6):1283-91. PubMed ID: 10871440
[TBL] [Abstract][Full Text] [Related]
15. Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes.
Lee TTM; Collett C; Bergford S; Hartnell S; Scott EM; Lindsay RS; Hunt KF; McCance DR; Barnard-Kelly K; Rankin D; Lawton J; Reynolds RM; Flanagan E; Hammond M; Shepstone L; Wilinska ME; Sibayan J; Kollman C; Beck R; Hovorka R; Murphy HR;
N Engl J Med; 2023 Oct; 389(17):1566-1578. PubMed ID: 37796241
[TBL] [Abstract][Full Text] [Related]
16. MiniMed
Guibert C; Amoura L; Rakotoarisoa L; Plat F; Sonnet E; Lablanche S; Tréglia C; Sarde E; Leca V; Rimareix F; Melki V; Baucher F; Betari B; Meyer L; Kessler L
Diabetes Technol Ther; 2023 Dec; 25(12):893-901. PubMed ID: 37956265
[No Abstract] [Full Text] [Related]
17. Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - Pump vs multiple daily injections, a secondary analysis of an observational cohort study.
Kjölhede K; Berntorp K; Kristensen K; Katsarou A; Shaat N; Wiberg N; Knop FK; Kristensen L; Dotevall A; Elfvin A; Sandgren U; Sengpiel V; Englund-Ögge L
Acta Obstet Gynecol Scand; 2021 May; 100(5):927-933. PubMed ID: 33176006
[TBL] [Abstract][Full Text] [Related]
18. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes.
Farrar D; Tuffnell DJ; West J; West HM
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD005542. PubMed ID: 27272351
[TBL] [Abstract][Full Text] [Related]
19. Day-and-Night Closed-Loop Insulin Delivery in a Broad Population of Pregnant Women With Type 1 Diabetes: A Randomized Controlled Crossover Trial.
Stewart ZA; Wilinska ME; Hartnell S; O'Neil LK; Rayman G; Scott EM; Barnard K; Farrington C; Hovorka R; Murphy HR
Diabetes Care; 2018 Jul; 41(7):1391-1399. PubMed ID: 29535135
[TBL] [Abstract][Full Text] [Related]
20. Continuous subcutaneous insulin infusion does not correspond with pregnancy outcomes despite better glycemic control as compared to multiple daily injections in type 1 diabetes - Significance of pregnancy planning and prepregnancy HbA1c.
Żurawska-Kliś M; Kosiński M; Kuchnicka A; Rurka M; Hałucha J; Wójcik M; Cypryk K
Diabetes Res Clin Pract; 2021 Feb; 172():108628. PubMed ID: 33358970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
